1003
|
Vaxelis
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
1004
|
Boostrix
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
1005
|
Infanrix
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
1009
|
Pentacel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited and Sanofi Pasteur SA
|
Approved
|
Intramuscular
|
NA
|
NCT00804284
|
1010
|
Daptacel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NCT00258895
|
1012
|
Quadracel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
1013
|
Adacel
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
1016
|
Tenivac
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
1018
|
DT Generic
|
Diphtheria
|
Corynebacterium diphtheriae
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
1038
|
Vaxelis
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
1039
|
Infanrix
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Inactivated
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
1043
|
Boostrix
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Inactivated
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
1044
|
Pentacel
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Inactivated
|
Sanofi Pasteur Limited and Sanofi Pasteur SA
|
Approved
|
Intramuscular
|
NA
|
NCT00804284
|
1045
|
Daptacel
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NCT00258895
|
1046
|
Quadracel
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
1047
|
Adacel
|
Pertussis (Whooping Cough)
|
Bordetella pertussis
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
1064
|
Vaxelis
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
1065
|
Infanrix
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
1069
|
Boostrix
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
GlaxoSmithKline Biologicals and GSK Vaccines GmbH
|
Approved
|
Intramuscular
|
NA
|
NA
|
1070
|
Pentacel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited and Sanofi Pasteur SA
|
Approved
|
Intramuscular
|
NA
|
NCT00804284
|
1071
|
Daptacel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NCT00258895
|
1072
|
Quadracel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
1073
|
Adacel
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
1076
|
Tenivac
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
1079
|
DT Generic
|
Tetanus (Lock Jaw)
|
Clostridium tetani
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
1101
|
Dukoral
|
Cholera
|
Vibrio cholerae
|
Inactivated
|
SBL Vaccines
|
Approved
|
Oral
|
31879125
|
NA
|
1102
|
Shanchol
|
Cholera
|
Vibrio cholerae
|
Inactivated
|
Shantha Biotechnics Limited
|
Approved
|
Oral
|
NA
|
NA
|
1103
|
Euvichol
|
Cholera
|
Vibrio cholerae
|
Inactivated
|
EuBiologics Co., Ltd.
|
Approved
|
Oral
|
31879125
|
NA
|
1104
|
Euvichol-plus
|
Cholera
|
Vibrio cholerae
|
Inactivated
|
EuBiologics Co., Ltd.
|
Approved
|
Oral
|
31879125
|
NA
|
1105
|
mORC-Vax
|
Cholera
|
Vibrio cholerae
|
Inactivated
|
Vabiotech, Hanoi
|
Approved
|
Oral
|
31879125
|
NA
|
1106
|
ORC-Vax
|
Cholera
|
Vibrio cholerae
|
Inactivated
|
Vabiotech, Hanoi
|
Approved
|
Oral
|
21498389
|
NA
|
1109
|
Plague Vaccine (by Greer Laboratories Inc.)
|
Plague
|
Yersinia pestis
|
Inactivated
|
Greer Laboratories Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
1110
|
Plague vaccine USP
|
Plague
|
Yersinia pestis
|
Inactivated
|
Cutter Biological Inc
|
Approved
|
NA
|
NA
|
NA
|
1116
|
Typhim Vi
|
Typhoid
|
Salmonella typhi
|
Inactivated
|
Sanofi Pasteur SA
|
Approved
|
Intramuscular
|
24599532
|
NA
|
1117
|
Typherix
|
Typhoid
|
Salmonella typhi
|
Inactivated
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
24599532
|
NA
|
1123
|
MENVEO
|
Meningococcal disease
|
Neisseria meningitidis
|
Inactivated
|
GSK Vaccines
|
Approved
|
Intramuscular
|
NA
|
NA
|
1124
|
Menactra
|
Meningococcal disease
|
Neisseria meningitidis
|
Inactivated
|
Sanofi Pasteur Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
1138
|
BIOTHRAX
|
Anthrax
|
Bacillus anthracis
|
Inactivated
|
Emergent BioDefense Operations
|
Approved
|
Intramuscular
|
NA
|
NA
|
1140
|
Prevnar 13
|
Pneumococcal
|
Streptococcus pneumoniae
|
Inactivated
|
Pfizer
|
Approved
|
Intramuscular
|
NA
|
NA
|
1141
|
Prevnar
|
Pneumococcal
|
Streptococcus pneumoniae
|
Inactivated
|
Wyeth Pharmaceuticals Inc.
|
Approved
|
Intramuscular
|
NA
|
NA
|
1146
|
Vaxelis
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Inactivated
|
Sanofi Pasteur Limited
|
Approved
|
Intramuscular
|
NA
|
NA
|
1147
|
Hiberix
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Inactivated
|
GlaxoSmithKline Biologicals
|
Approved
|
Intramuscular
|
NA
|
NA
|
1148
|
ActHib
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Inactivated
|
Sanofi Pasteur SA
|
Approved
|
Intramuscular
|
NA
|
NA
|
1152
|
Pentacel
|
Haemophilus influenzae type b (Hib)
|
Haemophilus influenzae
|
Inactivated
|
Sanofi Pasteur Limited and Sanofi Pasteur SA
|
Approved
|
Intramuscular
|
NA
|
NCT00804284
|
1168
|
Q-VAX
|
Q Fever
|
Coxiella burnetii
|
Inactivated
|
Seqirus Pty Ltd
|
Approved
|
Subcutaneous
|
NA
|
NA
|
1188
|
Sf2aWC
|
Bacillary Dysentery (Shigellosis)
|
Shigella genus
|
Inactivated
|
PATH
|
Clinical - Withdrawn
|
Oral
|
26865592
|
NCT03038243
|
1206
|
Spirolept
|
Leptospirosis
|
Leptospira genus
|
Inactivated
|
Imaxio
|
Clinical - Phase 4
|
Subcutaneous
|
NA
|
NCT03497572
|
1221
|
ETEC expressing CFA/I and CFA/II
|
E.coli Infections
|
Escherichia coli
|
Inactivated
|
NA
|
Clinical
|
Oral
|
NA
|
NA
|
1222
|
Gynevac
|
Bacterial Vaginosis
|
Gardnerella vaginalis, Lactobacillus, Prevotella, Mobiluncus, Bacteroides, Pepto streptococcus, Fusobacterium, Veillonella, Eubacterium, Mycoplasma hominis, Ureaplasma urealyticum, Streptococcus viridans and Atopobium vaginae.
|
Inactivated
|
Amvac Kft.
|
Clinical - Phase 3
|
Intramuscular
|
NA
|
NCT02173184
|
1229
|
NDBR 105
|
Q Fever
|
Coxiella burnetii
|
Inactivated
|
U.S. Army Medical Research and Development Command
|
Clinical - Withdrawn
|
Subcutaneous
|
NA
|
NCT02092142
|
1230
|
Chloroform-methanol residue (CMR)
|
Q Fever
|
Coxiella burnetii
|
Inactivated
|
NA
|
Clinical
|
Subcutaneous
|
8454328
|
NA
|
1240
|
Immuvac
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
Inactivated
|
Ministry of Science and Technology
|
Clinical - Phase 3
|
Intradermal
|
NA
|
NCT00265226
|
1243
|
RUTI
|
Pulmonary Tuberculosis (TB)
|
Mycobacterium tuberculosis
|
Inactivated
|
Archivel Farma S.L.
|
Clinical - Phase 2
|
NA
|
NA
|
NCT04919239
|
1319
|
Cholvax
|
Cholera
|
Vibrio cholerae
|
Inactivated
|
International Centre for Diarrhoeal Disease Research, Bangladesh
|
Clinical - Phase 2
|
Oral
|
31879125
|
NCT02742558
|
1320
|
Oral Cholera vaccine (in Vietnam)
|
Cholera
|
Vibrio cholerae
|
Inactivated
|
International Vaccine Institute
|
Clinical - Phase 2
|
Oral
|
NA
|
NCT00128011
|
1323
|
HL-OCV
|
Cholera
|
Vibrio cholerae
|
Inactivated
|
International Centre for Diarrhoeal Disease Research
|
Clinical - Phase 1, Phase 2
|
Oral
|
NA
|
NCT02823899
|